Condition: Diabetic Foot · Sponsor: PolarityTE
The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 2 diabetic foot ulcers.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Limb Preservation Platform, INC | Fresno, California, United States | — |
| LA Foot and Ankle Clinic | Los Angeles, California, United States | — |
| Royal Research, Corp | Hollywood, Florida, United States | — |
| Barry University Clinical Research | Tamarac, Florida, United States | — |
| Gateway Clinical Trials | O'Fallon, Illinois, United States | — |
| Boston Medical Center | Boston, Massachusetts, United States | — |
| Mount Sinai West | New York, New York, United States | — |
| Northwell Health | New York, New York, United States | — |
| VA North Texas Health Care System | Dallas, Texas, United States | — |
| University of Texas Southwestern Wound Care Clinic | Dallas, Texas, United States | — |
| Futuro Clinical Trials, LLC | McAllen, Texas, United States | — |
| Baylor Scott & White Research Institute - Plano | Plano, Texas, United States | — |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05372809